Stone tower and brick façade and colonnade of Sterling Law Building

Wednesday, September 6, 2023

Solomon Center Has Strong Showing at 46th Health Law Professors Conference

Members of the Solomon Center team presented at this year’s Health Law Professors Conference in Baltimore.

Thursday, August 17, 2023

Drugmakers Prep Medicare Pricing Suits for March to High Court

Bloomberg Law

Abbe R. Gluck ’00, Alfred M. Rankin Professor of Law and the founding Faculty Director of the Solomon Center for Health Law and Policy is quoted about upcoming challenges by major U.S. drug manufacturers to the Biden administration’s drug price negotiation program.

Thursday, June 8, 2023

The Legal Determinants of Health

Yale Insights

Alfred M. Rankin Professor of Law Abbe R. Gluck ’00 joins the Health & Veritas podcast to discuss how law shapes the health of Americans.

Friday, June 2, 2023

The Mifepristone Case and the Legitimacy of the FDA — A Commentary by Abbe Gluck ’00

JAMA Network

Abbe Gluck ’00 is the Alfred M. Rankin Professor of Law and Faculty Director of the Solomon Center for Health Law and Policy at Yale Law School.

computer screen showing COVID health information

Friday, May 19, 2023

The Law and the End of the COVID-19 Public Health Emergency

In recent pieces, Professors Abbe R. Gluck and Cristina Rodríguez have discussed what comes next for health law and immigration policies as official pandemic-era emergency declarations have come to an end.

Katie Attwell pointing at a screen

Associate Professor Katie Attwell of the University of Western Australia discussed how California’s vaccine laws have shaped the politics of vaccination in the state in a lecture co-hosted by the Solomon Center.

Wednesday, April 26, 2023

Lecture Explores How, For Vaccine Hesitant, Policies May Make Politics

Public policy scholar Katie Attwell discussed how California’s vaccine laws have shaped the politics of vaccination in the state in a lecture co-hosted by the Solomon Center.

A speaker at a podium with the words "FDA and the Public Trust: Ca0se 1" projected onto a screen while three panelists are seated in front of a chalkboard and audience members sit in rows

Dr. Aaron Kesselheim speaks at a panel hosted by the Solomon Center on the public’s trust in the FDA.

Tuesday, April 18, 2023

Solomon Center Welcomes Regulatory Experts for a Panel on FDA Public Trust

The Solomon Center for Health Law and Policy hosted a panel on the public’s trust of the U.S. Food and Drug Administration and its decision-making process. 

building roofline

Friday, April 14, 2023

Alumni Advise Health Law and Policy Students

The Yale Health Law and Policy Society (YHeLPS), in collaboration with the Solomon Center for Health Law and Policy, hosted its annual career night on April 13. Panelists spoke to students on their career paths in health law, providing diverse perspectives on their fields and their roles.

This year’s event featured six alumni panelists:

Four people are seated at a table in front of a chalkboard. A woman is standing, talking. A screen in front of the chalkboard has a projection of two additional panelists.

Solomon Center Interim Executive Director Jennifer Huer (standing) speaks at a panel on Health and Hospital Corporation of Marion County v. Talevski. Seated are, from left, panelists Maame Gyamfi and Andrew Tutt and students Cat Gassiot ’24, Melisa Olgun ’24. On the screen are panelists Jane Perkins (left) and Ira Burnim.

Tuesday, April 11, 2023

Panel Unpacks Supreme Court Case With Far-Reaching Implications For Medicaid and Beyond

Experts in Medicaid law discussed Supreme Court case Health and Hospital Corporation of Marion County v. Talevski, which could have far reaching impact for other federal programs.

Beatrice Brown ’25 and panelists Ameet Sarpatwari, Patricia Zettler, and Lewis Grossman.

Left to right: Panel moderator Beatrice Brown ’25 and panelists Ameet Sarpatwari, Patricia Zettler, and Lewis Grossman.

Thursday, April 6, 2023

Panel Examines Medication Abortion Access

The Solomon Center for Health Law and Policy hosted a panel discussion on issues related to medication abortion access and a recent challenge to the FDA’s approval of mifepristone.

Pages